CIK 0001088856 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 761.4 M | 401.9 M | ||
| Net income (USD) | 106.0 M | 94.2 M | ||
| Diluted EPS (USD/shares) | 0.82 | 0.87 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-05 | 4 | 4 | 2026-10-02 |
| 2026-10-05 | 4 | 4 | 2026-10-01 |
| 2026-10-05 | 4 | 4 | 2026-10-01 |
| 2026-10-05 | 4 | 4 | 2026-10-01 |
| 2026-10-05 | 3 | 3 | 2026-10-01 |
| 2026-10-01 | 144 | 144 | |
| 2026-09-28 | 4 | 4 | 2026-09-24 |
| 2026-09-23 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-09-22 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-18 | 4 | 4 | 2026-09-17 |
| 2026-09-16 | 4 | 4 | 2026-09-14 |
| 2026-09-16 | 4 | 4 | 2026-09-15 |
| 2026-09-15 | 144 | 144 | |
| 2026-09-14 | 144 | 144 | |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 3 | 3 | 2026-09-01 |
| 2026-09-02 | 144 | 144 | |
| 2026-08-28 | 4 | 4 | 2026-08-26 |
| 2026-08-27 | 4 | 4 | 2026-08-25 |
Forms on file (last 1,000): 4 541, 144 143, 8-K 102, SC 13G/A 43, 10-Q 32, 5 20, 3 13, DEF 14A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CORT (0.002 USD), /gw/filings/filings?ticker=CORT&form=8-K, /gw/filings/facts?ticker=CORT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange